NASDAQ · Health care

Akanda Corp. (AKAN)

Akanda Corp. reported revenue of $836.7K in fiscal 2024, up 97.5% from a year earlier. It posted a net loss of $4.1M. In fiscal 2024 capital spending exceeded operating cash flow by $6.1M. At December 31, 2024 it held $3.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on June 9, 2026.

Price

$3.05

-2.56% on the day · September 25, 2026

52-week range $2.30 to $209.23

Market cap

$1.6M

Revenue (FY2024)

$836.7K

+97.5% year on year

Net margin

-489.6%

What Akanda Corp. does

Akanda Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker AKAN.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2024	$836.7K	-$4.4M	-$4.1M	-$3.93	-$6.1M
2023	$423.7K	-$3.7M	-$32.3M	-$573.11	-$1.5M
2022	$2.6M	-$20.2M	-$11.7M	-$308.97	-$11.8M
2021	$41.4K	-$2.6M	-$8.1M	-$396.11	-$7.1M
2021	$2.1K	-$1.7M	-$2.3M	-$142.60	n/a
2019	n/a	-$901.2K	-$1.4M	-$87.14	n/a

Where AKAN ranks in Health care

Revenue$836.7K

#577 of 646 in Health care · Bottom 11%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Akanda Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 25, 2026
Foreign issuer update 6-K
September 9, 2026
Foreign issuer update 6-K
September 4, 2026
Foreign issuer update 6-K
August 17, 2026
Foreign issuer update 6-K
August 13, 2026
Foreign issuer update 6-K
June 18, 2026
Foreign issuer update 6-K
June 12, 2026
Foreign issuer update 6-K
June 9, 2026
Annual report (foreign issuer) 20-F · period to December 31, 2025
May 22, 2026
Foreign issuer update 6-K
May 13, 2026
Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 4, the latest on January 20, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about AKAN

What does Akanda Corp. do?

Akanda Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker AKAN.

Is Akanda Corp. profitable?

No. In fiscal 2024 it reported a net loss of $4.1M on revenue of $836.7K.

How much revenue does Akanda Corp. make?

In fiscal 2024 Akanda Corp. reported revenue of $836.7K. That is 97.5% more than a year earlier.

When did Akanda Corp. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 9, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 25, 2026.

Similar companies

TRLV

Trulieve Cannabis Corp.

SNDL

SNDL Inc.

USNA

Usana Health Sciences Inc

Compare AKAN with

Compare AKAN with any company

Follow AKAN

Get an email when Akanda Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow AKAN: get an email when it files

Where the numbers come from

Financial figures are the values Akanda Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.